drugset / Trial / NCT01771146
Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer
NaSingle-groupOpen-labelTreatment
Summary
A prospective evaluation of neoadjuvant FOLFIRINOX regimen in patients with non-metastatic pancreas cancer (Baylor University Medical Center and Texas Oncology Experience)
Timeline
- Start
- 2012-10
- Primary completion
- 2017-09
- Completion
- 2020-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | 180 mg/m2 | Intravenous |
| Subject | Oxaliplatin | Small molecule | 85 mg/m2 | Intravenous |
| Subject | fluorouracil | Small molecule | 2400 mg/m2 | Intravenous |